|
|
||||||||
MYCOLOGY |



Groupe d'Etude des Interactions Hôte-Parasite, Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire, 4 rue Larrey, 49033 Angers Cedex 01, *Laboratoire de Biotechnologie, UPRES 2161 Biocatalyse, 2 rue de la Houssinière, 44322 Nantes Cedex 03,
Laboratoire d'Immunologie, Centre Hospitalier Universitaire, 4 rue Larrey, 49033 Angers Cedex 01 and
Service Commun de Microscopie Electronique, Faculté de Médecine, rue Haute de Reculée, 49045 Angers, France
Corresponding author: Dr J-P. Bouchara (e-mail: Jean-Philippe.Bouchara{at}univ-angers.fr).
Present address: Département de Biologie, Faculté des Sciences, Université Moulay Ismail, Meknes, Morocco.
Received 25 Oct. 1999; revised version received 6 March 2000; accepted 23 March 2000.
Abstract
Two isolates of Candida glabrata from the same stool sample from a bone marrow transplant recipient treated with fluconazole, and designated 1084-L for large colonies on yeast extract-peptone-dextrose-agar and 1084-S for small colonies, were analysed. In-vitro susceptibility tests with a commercially available disk diffusion procedure showed that isolate 1084-L had a susceptibility pattern typical of wild-type strains of C. glabrata with sensitivity to polyenes and the presence of resistant colonies randomly distributed within the inhibition zones for all azole compounds except tioconazole. In contrast, isolate 1084-S, which was found by pulsed-field gel electrophoresis and random amplification of polymorphic DNA to be genetically closely related to isolate 1084-L, exhibited cross-resistance to the azole compounds except tioconazole. Determination of MICs by the E-test method confirmed these results, showing that isolate 1084-S had greater sensitivity to amphotericin B and complete resistance to ketoconazole and fluconazole. Growth on agar plates containing glucose or glycerol as the sole carbon source suggested that the resistant isolate had a respiratory deficiency, which was further demonstrated by flow cytometric analysis of the fluorescence of rhodamine 123-stained blastoconidia. Restriction endonuclease analysis of mitochondrial DNA (mtDNA) established the mitochondrial origin of the respiratory deficiency. However, PCR amplification of the mtDNA with primers ML1 and ML6, as well as transmission electron microscopy, suggested a partial deletion of the mtDNA analogous to that described for rho- petite mutants of Saccharomyces cerevisiae. Together, these results provided evidence that the selection of azole-resistant petite mutants of C. glabrata may occur in vivo after fluconazole administration, which might explain, therefore, clinical failure of antifungal therapy.
This article has been cited by other articles:
![]() |
P. Vandeputte, G. Tronchin, G. Larcher, E. Ernoult, T. Berges, D. Chabasse, and J.-P. Bouchara A Nonsense Mutation in the ERG6 Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of Candida glabrata Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3701 - 3709. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Oliver, P. M. Silver, C. Marie, S. J. Hoot, S. E. Leyde, and T. C. White Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi Microbiology, March 1, 2008; 154(3): 960 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gulshan and W. S. Moye-Rowley Multidrug Resistance in Fungi Eukaryot. Cell, November 1, 2007; 6(11): 1933 - 1942. [Full Text] [PDF] |
||||
![]() |
S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1855 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Miller, J. D. Dick, and W. G. Merz Phenotypic Switching in Candida lusitaniae on Copper Sulfate Indicator Agar: Association with Amphotericin B Resistance and Filamentation J. Clin. Microbiol., April 1, 2006; 44(4): 1536 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brun, F. Dalle, P. Saulnier, G. Renier, A. Bonnin, D. Chabasse, and J.-P. Bouchara Biological consequences of petite mutations in Candida glabrata J. Antimicrob. Chemother., August 1, 2005; 56(2): 307 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brun, T. Berges, P. Poupard, C. Vauzelle-Moreau, G. Renier, D. Chabasse, and J.-P. Bouchara Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1788 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brun, C. Aubry, O. Lima, R. Filmon, T. Berges, D. Chabasse, and J.-P. Bouchara Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata Antimicrob. Agents Chemother., March 1, 2003; 47(3): 847 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanglard, F. Ischer, and J. Bille Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1174 - 1183. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |